Nancy E. Denyes
General Counsel and Corporate Secretary
General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | aTYR PHARMA INC (ATYR) | — | $451,570 | $1,284,841 |
| 2024 | aTYR PHARMA INC (ATYR) | — | $410,517 | $729,305 |
| 2023 | aTYR PHARMA INC (ATYR) | — | $396,635 | $651,283 |
| 2021 | aTYR PHARMA INC (ATYR) | — | $360,577 | $891,288 |
| 2020 | aTYR PHARMA INC (ATYR) | — | $350,075 | $625,257 |
| 2019 | aTYR PHARMA INC (ATYR) | — | $335,000 | $449,263 |
Earnings-call appearances
No earnings-call appearances recorded yet.